| Better Care Medical Group, Inc. | |
|
1153 S Garfield Ave Alhambra CA 91801-4714 | |
| (626) 281-1961 | |
| (626) 281-6564 |
| Full Name | Better Care Medical Group, Inc. |
|---|---|
| Speciality | Family Medicine |
| Location | 1153 S Garfield Ave, Alhambra, California |
| Authorized Official Name and Position | Lien Morning (OFFICE MANAGER) |
| Authorized Official Contact | 6262811961 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Better Care Medical Group, Inc. 1153 S Garfield Ave Alhambra CA 91801-4714 Ph: (626) 281-1961 | Better Care Medical Group, Inc. 1153 S Garfield Ave Alhambra CA 91801-4714 Ph: (626) 281-1961 |
| NPI Number | 1609061811 |
|---|---|
| Provider Enumeration Date | 09/11/2007 |
| Last Update Date | 07/10/2008 |
| Medicare PECOS PAC ID | 4688723497 |
|---|---|
| Medicare Enrollment ID | O20090528000187 |
News Archive
Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that its development partner, Janssen R&D Ireland has broadened its clinical collaboration agreement with Bristol-Myers Squibb Company.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces clinical results from ENCORE 401, a double-blind, placebo-controlled phase 2 trial, in patients with advanced non-small cell lung cancer (NSCLC). The results show that there was a survival advantage in the subset of patients with elevated E-cadherin (a molecular marker of epithelial tumors) receiving entinostat in combination with erlotinib (Tarceva®).
"A monthly survey of consumer sentiment on health care issues shows that Americans' confidence in insurance coverage, affordability and access dropped more than 5 points in July, after having risen slightly in June," The Associated Press/CBS News reports.
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine report that small molecule inhibitors to a protein called focal adhesion kinase (FAK) selectively prevent the growth of ovarian cancer cells as tumor spheroids.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609061811 | NPI | - | NPPES |
| 00A383980 | Other | CA | MEDI-CAL |
| 00A383980 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (California) | Primary |
| 207R00000X | Internal Medicine | (* (Not Available)) | Secondary |
| Provider Name | Theresa Tseng |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558466979 PECOS PAC ID: 5395894109 Enrollment ID: I20090528000230 |
News Archive
Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that its development partner, Janssen R&D Ireland has broadened its clinical collaboration agreement with Bristol-Myers Squibb Company.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces clinical results from ENCORE 401, a double-blind, placebo-controlled phase 2 trial, in patients with advanced non-small cell lung cancer (NSCLC). The results show that there was a survival advantage in the subset of patients with elevated E-cadherin (a molecular marker of epithelial tumors) receiving entinostat in combination with erlotinib (Tarceva®).
"A monthly survey of consumer sentiment on health care issues shows that Americans' confidence in insurance coverage, affordability and access dropped more than 5 points in July, after having risen slightly in June," The Associated Press/CBS News reports.
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine report that small molecule inhibitors to a protein called focal adhesion kinase (FAK) selectively prevent the growth of ovarian cancer cells as tumor spheroids.
› Verified 2 days ago
| Provider Name | Byron H Lin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1104866649 PECOS PAC ID: 5698775765 Enrollment ID: I20090602000188 |
News Archive
Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that its development partner, Janssen R&D Ireland has broadened its clinical collaboration agreement with Bristol-Myers Squibb Company.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces clinical results from ENCORE 401, a double-blind, placebo-controlled phase 2 trial, in patients with advanced non-small cell lung cancer (NSCLC). The results show that there was a survival advantage in the subset of patients with elevated E-cadherin (a molecular marker of epithelial tumors) receiving entinostat in combination with erlotinib (Tarceva®).
"A monthly survey of consumer sentiment on health care issues shows that Americans' confidence in insurance coverage, affordability and access dropped more than 5 points in July, after having risen slightly in June," The Associated Press/CBS News reports.
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine report that small molecule inhibitors to a protein called focal adhesion kinase (FAK) selectively prevent the growth of ovarian cancer cells as tumor spheroids.
› Verified 2 days ago
News Archive
Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that its development partner, Janssen R&D Ireland has broadened its clinical collaboration agreement with Bristol-Myers Squibb Company.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces clinical results from ENCORE 401, a double-blind, placebo-controlled phase 2 trial, in patients with advanced non-small cell lung cancer (NSCLC). The results show that there was a survival advantage in the subset of patients with elevated E-cadherin (a molecular marker of epithelial tumors) receiving entinostat in combination with erlotinib (Tarceva®).
"A monthly survey of consumer sentiment on health care issues shows that Americans' confidence in insurance coverage, affordability and access dropped more than 5 points in July, after having risen slightly in June," The Associated Press/CBS News reports.
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine report that small molecule inhibitors to a protein called focal adhesion kinase (FAK) selectively prevent the growth of ovarian cancer cells as tumor spheroids.
› Verified 2 days ago
Ssg Apctc Alhambra Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1635 W Main St Ste 100, Alhambra, CA 91801 Phone: 626-248-1800 | |
Patient Care Medical Center Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 320 S Garfield Ave Ste 206, Alhambra, CA 91801 Phone: 626-607-9406 Fax: 626-458-2489 | |
Thelma V Buan Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 123 N Garfield Ave, Suite C, Alhambra, CA 91801 Phone: 626-308-3781 Fax: 626-308-2113 | |
Paul Hovsepian, M.d. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 103 N Garfield Ave, Suite F, Alhambra, CA 91801 Phone: 626-282-2100 Fax: 626-281-0969 | |
Thida Win Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 100 S Raymond Ave, Alhambra, CA 91801 Phone: 626-677-8218 | |
Apc-lsma Designated Shareholder Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 925 S Garfield Ave, Alhambra, CA 91801 Phone: 626-282-0282 | |
Ap-amh 2 Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1668 S Garfield Ave Fl 2, Alhambra, CA 91801 Phone: 626-282-0288 |